ResearcherSun Yat-sen University Cancer CenterActive in the last 2 years

Ming-Ming He

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4706-6093; OpenAlex author ID A5079687568. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 2

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Yun‐Xin Lu · 1 shared paper, 2025 · strength 0.20
- Paper Efficacy and safety of TAS-102 plus Surufatinib in third and later line metastatic pancreatic cancer: a prospective, si… DOI 10.1186/s12943-025-02437-0 ↗
Dongsheng Zhang · 1 shared paper, 2025 · strength 0.20
- Paper Efficacy and safety of TAS-102 plus Surufatinib in third and later line metastatic pancreatic cancer: a prospective, si… DOI 10.1186/s12943-025-02437-0 ↗
Feng Wang · 1 shared paper, 2025 · strength 0.20
- Paper Efficacy and safety of TAS-102 plus Surufatinib in third and later line metastatic pancreatic cancer: a prospective, si… DOI 10.1186/s12943-025-02437-0 ↗
Feng‐Hua Wang · 1 shared paper, 2025 · strength 0.20
- Paper Efficacy and safety of TAS-102 plus Surufatinib in third and later line metastatic pancreatic cancer: a prospective, si… DOI 10.1186/s12943-025-02437-0 ↗
Yu-Tong Chen · 1 shared paper, 2016 · strength 0.08
- Paper Equipping the American Joint Committee on Cancer staging for resectable pancreatic ductal adenocarcinoma with tumor gra… DOI 10.1007/s12032-016-0839-4 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.